Alnylam Pharmaceuticals (ALNY) to Webcast Presentation at Leerink Swann and Company Rare Disease Roundtable
9/26/2013 6:45:53 AM
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Leerink Swann Rare Disease Roundtable on Wednesday, October 2, 2013 at 2:00 p.m. ET at Le Parker Meridien Hotel in New York City.
A live audio webcast of the presentation will be available on the News & Investors section of the company’s website, www.alnylam.com. A replay of the presentation will be available on the Alnylam website within 48 hours after the event.
Help employers find you! Check out all the jobs and post your resume.